Biomedical Engineering Reference
In-Depth Information
59. Ferrara N (1999) Role of vascular endothelial growth
factor in the regulation of angiogenesis. Kidney Int
56:794-814.
60. Ferrara N (2000) VEGF: an update on biological
and therapeutic aspects. Curr Opin Biotechnol 11:
617-624.
61. Ferrara N (2001) Role of vascular endothelial
growth factor in regulation of physiological angio-
genesis. Am J Physiol Cell Physiol 280:C1358-
C1366.
62. Fitzpatrick LA, Coleman DT, Bilezikian JP (1992)
The target tissue actions of parathyroid hormone.
In: Coe FL, Favus MJ, eds. Disorders of Bone and
Mineral Metabolism. New York: Raven Press,
pp 123-147.
63. Fukuhara H, Mizuno K (1989) The infl uence of para-
thyroid hormone on the process of fracture healing.
Nippon Seikeigeka Gakkai Zasshi 63:100-115.
64. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ
(2003) Stimulation of BMP-2 expression by pro-
infl ammatory cytokines IL-1 and TNF-alpha in
normal and osteoarthritic chondrocytes. J Bone
Joint Surg Am 85A:59-66.
65. Gardella TJ, Jüppner H (2001) Molecular properties
of the PTH/PTHrP receptor. Trends Endocrinol
Metab 12:210-217.
66. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z,
Ferrara N (1999) VEGF couples hypertrophic carti-
lage remodeling, ossifi cation and angiogenesis
during endochondral bone formation. Nat Med
5:623-628.
67. Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME,
Hennig GE, Hipp J, Schelling SH, Wang E (1993)
Healing segmental femoral defects in sheep using
recombinant human bone morphogenetic protein.
Clin Orthop 293:317-326.
68. Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Cruceta J,
Graves BD, Einhorn TA (2001) Impaired intramem-
branous bone formation during bone repair in the
absence of tumor necrosis factor-alpha signaling.
Cells Tissues Organs 169:285-294.
69. Gerstenfeld LC, Cho T-J, Kon T, Aizawa T, Tsay A,
Fitch J, Barnes GL, Graves DT, Einhorn TA (2003)
Impaired fracture healing in the absence of TNF-
alpha signaling: the role of TNF-alpha in endochon-
dral cartilage resorption. J Bone Miner Res
18:1584-1592.
70. Gerstenfeld LC, Cruceta J, Shea CM, Sampath K,
Barnes GL, Einhorn TA (2002) Chondrocytes provide
morphogenic signals that selectively induce osteo-
genic differentiation of mesenchymal stem cells.
J Bone Miner Res 17:221-230.
71. Gerstenfeld LC, Shapiro FD (1996) Expression of
bone-specifi c genes by hypertrophic chondrocytes:
implication of the complex functions of the hyper-
trophic chondrocyte during endochondral bone
development. J Cell Biochem 62:1-9.
72. Gibson GJ, Kohler WJ, Schaffl er MB (1995) Chondro-
cyte apoptosis in endochondral ossifi cation of chick
sterna. Dev Dyn 203:468-476.
73. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman
S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev
D, Zacharin M, Oexle K, Marcelino J, Suwairi W,
Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove
J, Arslan-Kirchner M, Batch JA, Beighton P, Black
GC, Boles RG, Boon LM, Borrone C, Brunner HG,
Carle GF, Dallapiccola B, De Paepe A, Floege B, Half-
hide ML, Hall B, Hennekam RC, Hirose T, Jans A,
Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter
A, LaCombe D, Lambert M, Lemyre E, Letteboer T,
Peltonen L, Ramesar RS, Romanengo M, Somer H,
Steichen-Gersdorf E, Steinmann B, Sullivan B,
Superti-Furga A, Swoboda W, van den Boogaard MJ,
Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia
T, Baron R, Olsen BR, Warman ML, for the Osteopo-
rosis-Pseudoglioma Syndrome Collaborative Group
(2001) LDL receptor-related protein 5 (LRP5) affects
bone accrual and eye development. Cell 107:513-
523.
74. Goralczyk R, Closs EI, Ruther U, Wagner EF, Strauss
PG, Erfl e V, Schmidt J (1990) Characterization of fos-
induced osteogenic tumours and tumour-derived
murine cell lines. Differentiation 44:122-131.
75. Gravallese EM, Pettit AR, Lee R, Madore R, Manning
C, Tsay A, Gaspar J, Goldring MB, Goldring SR,
Oettgen P (2003) Angiopoietin-1 is expressed in the
synovium of patients with rheumatoid arthritis and
is induced by tumor necrosis factor alpha. Ann
Rheum Dis 62:100-107.
76. Guo J, Chung UI, Kondo H, Bringhurst FR, Kronen-
berg HM (2002) The PTH/PTHrP receptor can delay
chondrocyte hypertrophy in vivo without activating
phospholipase C. Dev Cell 3:183-194.
77. Habener JF (1990) Cyclic AMP response element
binding proteins: a cornucopia of transcription
factors. Mol Endocrinol 4:1087-1094.
78. Harbour ME, Gregory JW, Jenkins HR, Evans BA
(2000) Proliferative response of different human
osteoblast-like cell models to proinfl ammatory cyto-
kines. Pediatr Res 48:163-168.
79. Haridas V, Shrivastava A, Su J, Yu GL, Ni J, Liu D,
Chen SF, Ni Y, Ruben SM, Gentz R, Aggarwal BB
(1999) VEGI, a new member of the TNF family acti-
vates nuclear factor-kappa B and c-Jun N-terminal
kinase and modulates cell growth. Oncogene
18:6496-6504.
80. Harper J, Gerstenfeld LC, Klagsbrun M (2001) Neu-
ropilin-1 expression in osteogenic cells: down-regu-
lation during differentiation of osteoblasts into
osteocytes. J Cell Biochem 81:82-92.
81. Hartmann C, Tabin CJ (2000) Dual roles of Wnt sig-
naling during chondrogenesis in the chicken limb.
Development 127:3141-3159.
82. Harty M, Neff AW, King MW, Mescher AL (2003)
Regeneration or scarring: an immunologic perspec-
tive. Dev Dyn 226:268-279.
83. Hashimoto S, Setareh M, Ochs R, Lotz M (1997) Fas/
Fas ligand expression and induction of apoptosis in
chondrocytes. Arthritis Rheum 40:1749-1755.
84. Hausman MR, Schaffl er MB, Majeska RJ (2001) Pre-
vention of fracture healing in rats by an inhibitor of
angiogenesis. Bone 29:560-564.
85. Hock JM, Gera I (1992) Effects of continuous and
intermittent administration and inhibition of resorp-
tion on the anabolic response of bone to parathyroid
hormone. J Bone Miner Res 7:65-72.
86. Hofmann C, Luo G, Balling R, Karsenty G (1996)
Analysis of limb patterning in BMP-7-defi cient mice.
Dev Genet 19:43-50.
87. Holash J, Wiegand SJ, Yancopoulos GD (1999) New
model of tumor angiogenesis: dynamic balance
between vessel regression and growth mediated
